Article
Vaccine effectiveness estimates from an early-season influenza A(H3N2) epidemic, including unique genetic diversity with reassortment, Canada, 2022/23.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin - 1 Feb 2023
Skowronski Danuta M, Chuang Erica Sy, Sabaiduc Suzana, Kaweski Samantha E, Kim Shinhye, Dickinson James A, Olsha Romy, Gubbay Jonathan B, Zelyas Nathan, Charest Hugues, Bastien Nathalie, Jassem Agatha N, De Serres Gaston
Abstract excerpt
The Canadian Sentinel Practitioner Surveillance Network estimated vaccine effectiveness (VE) during the unusually early 2022/23 influenza A(H3N2) epidemic. Like vaccine, circulating viruses were clade 3C.2a1b.2a.2, but with genetic diversity affecting haemagglutinin positions 135 and 156, and reassortment such that H156 viruses acquired neuraminidase from clade 3C.2a1b.1a. Vaccine provided substantial protection...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
